Trade JnJ ^JNJ

Johnson & Johnson (JNJ) Expected to Announce Earnings on Tuesday

Medical Stocks To Watch Today - April 6th - Markets Daily

$10,000 to Invest? Coca-Cola or Johnson & Johnson- One Stock Is More Reliable - AOL

One Approved, Six on the Way: Is the pVAD Market Becoming Competitive in Its Launch Year?

The Exact Portfolio Size Required to Live Entirely Off Dividends Instead of Your $60,000 Paycheck

ICOTYDE Psoriasis Data And JNJ-4804 Funding Could Be A Game Changer For Johnson & Johnson (JNJ) - Simply Wall St News

Aberdeen Group plc Buys 47,996 Shares of Johnson & Johnson $JNJ

Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won't Pay a Dime | Investing.com

Dividend News and Commentary

Johnson & Johnson $JNJ Stock Position Raised by Trust Co. of Vermont

Best Healthcare Stocks To Add to Your Watchlist - April 5th - Daily Political

HF Advisory Group LLC Raises Stock Position in Johnson & Johnson $JNJ

Banque Pictet & Cie SA Buys 14,562 Shares of Johnson & Johnson $JNJ

9,408 Shares in Johnson & Johnson $JNJ Bought by Dorato Capital Management

Assessing Johnson & Johnson (JNJ) Valuation After Autoimmune Pipeline Advances And New R&D Partnership - Simply Wall St News

Triad Investment Management Invests $1.05 Million in Johnson & Johnson $JNJ

Promising Healthcare Stocks To Consider - April 4th - Daily Political

Tema Etfs LLC Boosts Stock Holdings in Johnson & Johnson $JNJ

PineStone Asset Management Inc. Reduces Stake in Johnson & Johnson $JNJ

Compagnie Lombard Odier SCmA Grows Stock Holdings in Johnson & Johnson $JNJ

Johnson & Johnson Cardiac Trial Data Refines Impella Role In MedTech Story

Johnson And Johnson Expands Sirturo Reach In Japan With KYORIN Deal

Real-world evidence for comparative safety of second-line antihyperglycemic agents in older adults with type 2 diabetes

Comparing 2 Healthcare Giants: Which Dividend Aristocrat Will Keep Paying Out for Generations to Come?

Is It Time To Reassess Kenvue (KVUE) After Its Separation From Johnson & Johnson? - Simply Wall St News

Erste Group Remains a Buy on Johnson & Johnson (JNJ) | Markets Insider

The S&P 500 Without Big Tech Is Quietly Beating the Full Index in 2026 - AOL

The S&P 500 Without Big Tech Is Quietly Beating the Full Index in 2026 - 24/7 Wall St.

Johnson & Johnson $JNJ Shares Sold by Meyer Handelman Co.

Shrier Wealth Management LLC Buys Shares of 12,462 Johnson & Johnson $JNJ - Markets Daily

Shrier Wealth Management LLC Acquires Shares of 12,462 Johnson & Johnson $JNJ - Stock Observer

Johnson & Johnson $JNJ Stock Holdings Lifted by Royal Fund Management LLC - Stock Observer

Nisa Investment Advisors LLC Sells 288,435 Shares of Johnson & Johnson $JNJ - Stock Observer

Meyer Handelman Co. Sells 5,430 Shares of Johnson & Johnson $JNJ - Daily Political

Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease

Pharmaceutical Companies Pfizer, Johnson & Johnson Paid $12.6 Million in Bribes for Approvals, Contracts

Tumor Microenvironment Market to Reach Over $2.7 Billion by 2030 - Rising Demand for Personalized Oncology Therapies and Next-Gen Immunotherapies Driving the Industry

Metastatic Lung Adenocarcinoma Treatment Market Outlook Report 2026-2030: Targeted Therapies Fuel Growth, with Revenues Reaching $5 Billion by 2030

Medical Stocks To Research - April 2nd - Stock Observer

Why Johnson & Johnson (JNJ) Is One of the Best Pharma Stocks to Invest in Now

This Healthcare Stock Barely Flinches During Market Sell-Offs

Is It Too Late To Consider Johnson & Johnson (JNJ) After Its 61% One-Year Surge?

J. Safra Sarasin Holding AG Lowers Position in Johnson & Johnson $JNJ

Stagflation Fears Are Back: These 3 Stocks Can Help You Ride Out the Storm

11,271 Shares in Johnson & Johnson $JNJ Bought by Financial Planning Hawaii Inc.

J. Safra Sarasin Holding AG Reduces Stock Position in Johnson & Johnson $JNJ - Stock Observer

Mn Services Vermogensbeheer B.V. Increases Position in Johnson & Johnson $JNJ - Daily Political

Royalty Pharma, Johnson & Johnson Strike $500M Autoimmune Drug Deal

Johnson & Johnson (JNJ): Billionaire Ray Dalio Trims Position

Change in Orion Group Executive Team as of 8 April 2026 - Berkeley Vincent appointed Executive Vice President, Innovative Medicines

World Investment Advisors Acquires 26,450 Shares of Johnson & Johnson $JNJ

World Investment Advisors Purchases 26,450 Shares of Johnson & Johnson $JNJ - Markets Daily

Inside Johnson & Johnson: Uncovering Decades of Deadly Corporate Practices - Frontline

Nanobiotix H2 Earnings Call Highlights - Stock Observer

Doxorubicin Market Outlook 2026-2030 & 2035: Predicted to Surge to $2 Billion by 2030, Bolstered by Expanding Access to Cancer Care

ORS labelling row: Hyderabad paediatrician Sivaranjani Santosh refuses to back down amid pressure - The Hindu

Best Healthcare Stocks To Add to Your Watchlist - April 1st - Daily Political

Volatility Is Spiking. Here Are 3 Dividend Stocks You Can Buy Without Hesitation.

Johnson & Johnson Taps Royalty Pharma To Support Immunology Growth Plans - Simply Wall St News

A mathematical framework for thermodynamic computing with applications to chemical reaction networks

Why Johnson & Johnson Is Rebounding - Finally - Yahoo News Canada

Johnson & Johnson (JNJ) Benefits from Growth Pipeline and Strength Across Key Therapeutic Areas

Jim Cramer Highlights Johnson & Johnson Stock's "Free Fall" and Rise Despite Lawsuits

Here's Why You Don't Bet Against This Dividend King

Extreme Fear is Gripping the Market, This Is the Smart Move Most Investors Miss

Wedge Capital Management L L P NC Lowers Holdings in Johnson & Johnson $JNJ

Chesley Taft & Associates LLC Buys 14,776 Shares of Johnson & Johnson $JNJ

Hunter Perkins Capital Management LLC Sells 22,056 Shares of Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson (NYSE:JNJ) - Stock Analysis - Simply Wall St

JNJ - Johnson & Johnson (JNJ): The $100 Billion Revenue Frontier and the MedTech Evolution

Johnson & Johnson's JNJ-4804 Deal Adds Weight To Immunology Story

Iran Conflict Rattles Stocks - Jim Cramer's Game Plan and 9 Stock Calls

Healthcare Stocks To Keep An Eye On - March 30th - Daily Political

Johnson Bixby & Associates LLC Buys 102,219 Shares of Schwab Fundamental Emerging Markets Equity ETF $FNDE - Markets Daily

Johnson & Johnson $JNJ Shares Sold by Pallas Capital Advisors LLC

Global X Japan Co. Ltd. Has $15.96 Million Stake in Johnson & Johnson $JNJ

Non-Muscle Invasive Bladder Cancer (NMIBC) Market to Grow by $1 Billion During 2026-2030 - Johnson & Johnson, Janssen Research & Development, and Merck & Co. Lead the Competition

TABR Capital Management LLC Buys New Shares in Johnson & Johnson $JNJ

$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030

Exchange Traded Concepts LLC Decreases Stake in Johnson & Johnson $JNJ

CoreCap Advisors LLC Boosts Stake in Johnson & Johnson $JNJ

Capital Investment Advisors LLC Increases Position in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Stock Position Trimmed by Avity Investment Management Inc.

NANOBIOTIX annonce la présentation des premières données de l'étude de phase 2 randomisée évaluant JNJ-1900 (NBTXR3) dans le cancer du poumon inopérable de stade III

Johnson And Johnson's Darzalex Home Use Approval Reshapes Myeloma Care Narrative

Johnson Bixby & Associates LLC Has $20 Million Stake in Capital Group Core Plus Income ETF $CGCP - Daily Political

Does J&J-Backed MRT-2359 Prostate Cancer Trial Change The Bull Case For Monte Rosa Therapeutics (GLUE)? - Simply Wall St News

Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myeloma

Best Medical Stocks To Follow Today - March 29th - Markets Daily

J&J announces new long-term 52-week data from Phase 3 Iconic-Advance 1, 2 | Markets Insider

Top Healthcare Stocks To Keep An Eye On - March 29th - Stock Observer

 Week Ahead: Inflation Data from U.S., Canada, and U.K. Take Centre Stage

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Week ahead: ECB set to cut as Wall Street earnings season gathers pace

Week ahead: US earnings season kicks off, ECB hold expected

Europe Tries to Ride on US Coat-tails

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk